Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Director | August 09, 2019 | August 13, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEMAITRE VASCULAR INC
Report date August 09, 2019 · Filed August 13, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2019-08-09 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2019-08-09 · Exercise / conversion · Acquired 7,500 · Balance 15,000 F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Row 2 · 2019-08-09 · Sale · Disposed 7,500 · Balance 7,500 F2: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $32.14 to $32.33. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Row 3 · 2019-08-09 · Sale · Disposed 7,500 · Balance 0 F3: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $32.00 to $32.17. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.43 · Expires 2020-07-23 | Direct | 0 |
Reported balance
After 2019-08-09 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-08-09 · Exercise / conversion · Disposed 7,500 · Balance 0 F4: This option is fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $32.14 to $32.33. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F3: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $32.00 to $32.17. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F4: This option is fully vested and exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 09, 2019 Filed Aug 13, 2019 20:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $11.43 | $0.00 |
DisclosureSEC source: 0001437749-19-016553 · rdgdoc.xml · derivative · entry 4 Thomas Michael H · CIK 0001591272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2020-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 20:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 7,500 | $32.05 | $240,402.75 |
DisclosureSEC source: 0001437749-19-016553 · rdgdoc.xml · nonDerivative · entry 3 Thomas Michael H · CIK 0001591272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $32.00 to $32.17. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 20:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 7,500 | $32.15 | $241,157.25 |
DisclosureSEC source: 0001437749-19-016553 · rdgdoc.xml · nonDerivative · entry 2 Thomas Michael H · CIK 0001591272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $32.14 to $32.33. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 20:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 7,500 | $11.43 | $85,725.00 |
DisclosureSEC source: 0001437749-19-016553 · rdgdoc.xml · nonDerivative · entry 1 Thomas Michael H · CIK 0001591272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| July 09, 2019 Filed Jul 11, 2019 20:32 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $7.87 | $0.00 |
DisclosureSEC source: 0001437749-19-013853 · rdgdoc.xml · derivative · entry 2 Thomas Michael H · CIK 0001591272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2019-07-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| July 09, 2019 Filed Jul 11, 2019 20:32 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 7,500 | $7.87 | $59,025.00 |
DisclosureSEC source: 0001437749-19-013853 · rdgdoc.xml · nonDerivative · entry 1 Thomas Michael H · CIK 0001591272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 19, 2018 Filed Dec 21, 2018 21:27 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $23.56 | $0.00 |
DisclosureSEC source: 0001209191-18-063919 · doc4.xml · derivative · entry 1 Thomas Michael H · CIK 0001591272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2023-12-19 F1 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| October 30, 2018 Filed Nov 1, 2018 20:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $8.02 | $0.00 |
DisclosureSEC source: 0001209191-18-056749 · doc4.xml · derivative · entry 3 Thomas Michael H · CIK 0001591272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2018-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| October 30, 2018 Filed Nov 1, 2018 20:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 20,000 | $27.93 | $558,588.00 |
DisclosureSEC source: 0001209191-18-056749 · doc4.xml · nonDerivative · entry 2 Thomas Michael H · CIK 0001591272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $27.80 to $28.07. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| October 30, 2018 Filed Nov 1, 2018 20:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 20,000 | $8.02 | $160,400.00 |
DisclosureSEC source: 0001209191-18-056749 · doc4.xml · nonDerivative · entry 1 Thomas Michael H · CIK 0001591272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 22, 2017 Filed Dec 28, 2017 01:48 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $31.30 | $0.00 |
DisclosureSEC source: 0001209191-17-067484 · doc4.xml · derivative · entry 1 Thomas Michael H · CIK 0001591272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2022-12-22 F1 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.